From DCAT Value Chain Insights (VCI)
Biogen has appointed Anirvan Ghosh, PhD, as senior vice president, research and early development (RED), effective in April 2017. Dr. Ghosh will lead Biogen’s RED organization in the discovery and development of drug candidates. He will report to Michael Ehlers, MD, PhD, executive vice president, head of research and development.
Dr. Ghosh joins Biogen from E-Scape Bio, a South San Francisco, California-based biotechnology company, where he served as chief scientific officer. Prior to heading discovery efforts for Alzheimer’s disease and neurodegenerative disorders at E-Scape Bio, he served as vice president, global head of neuroscience discovery and biomarkers at Roche. In that capacity, Dr. Ghosh led research and drug discovery for programs addressing neurodegenerative diseases as well as neurodevelopmental and psychiatric disorders.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription